Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma

作者
Eu Chang Hwang,Niranjan Jude Sathianathen,Jae Hung Jung,Myung Ha Kim,Philipp Dahm,Michael Christopher Risk
出处
期刊:The Cochrane library [Wiley]
卷期号:2019 (5): CD013160-CD013160 被引量:54
标识
DOI:10.1002/14651858.cd013160.pub2
摘要

BACKGROUND: Single-dose, postoperative intravesical chemotherapy reduces the risk of bladder cancer recurrence after transurethral resection of bladder tumours. However, there is limited evidence whether single-dose intravesical chemotherapy is similarly effective at preventing bladder cancer recurrence after nephroureterectomy. OBJECTIVES: To assess the effects of single-dose intravesical chemotherapy instillation after nephroureterectomy for upper tract urothelial carcinoma. SEARCH METHODS: We performed a comprehensive literature search using multiple databases (MEDLINE, Cochrane Library, Embase, Scopus, Web of Science, and LILACS), trials registries, other sources of grey literature, and conference proceedings published up to April 15 2019, with no restrictions on language or status of publication. SELECTION CRITERIA: We included randomised controlled trials in which participants either received or did not receive single-dose intravesical chemotherapy instillation after nephroureterectomy. DATA COLLECTION AND ANALYSIS: Two review authors screened and independently assessed studies and extracted data from included studies. We performed statistical analyses using a random-effects model. We rated the certainty of evidence according to the GRADE approach. MAIN RESULTS: The search identified two studies (a multicenter study from Japan and the United Kingdom) with 361 participants.Primary outcomesOur results indicate that single-dose intravesical chemotherapy instillation may reduce the risk of bladder cancer recurrence over time compared to no instillation (hazard ratio [HR]: 0.51, 95% confidence interval [CI]: 0.32 to 0.82, low-certainty evidence). After 12 months follow-up, this would result in 127 fewer bladder cancer recurrences (95% CI: 182 to 44 fewer bladder cancer recurrences) per 1000 participants. We downgraded the certainty of evidence by two levels due to study limitations and imprecision.We found no trials that reported on the outcomes of time to death from upper tract urothelial carcinoma. The effect of single-dose intravesical chemotherapy instillation on serious adverse events is uncertain (risk ratio [RR]: not estimable, 95% CI: not estimable, there were no events, very low-certainty evidence). We downgraded the certainty of evidence by one level due to study limitations and by two levels due to imprecision.Secondary outcomesWe found no trials that reported on the outcomes of time to death from any cause and participants' disease-specific quality of life. The effect of single-dose intravesical chemotherapy instillation on minor adverse events is uncertain (risk ratio [RR]: not estimable, 95% CI: not estimable, there were no events, very low-certainty evidence). We downgraded the certainty of evidence by one level due to study limitations and by two levels due to imprecision. AUTHORS' CONCLUSIONS: For patients who have undergone nephroureterectomy for upper tract urothelial carcinoma, single-dose intravesical chemotherapy instillation may reduce bladder cancer recurrence after nephroureterectomy. However, we are uncertain as to the risk of serious (and minor) adverse events. We found no evidence for the outcome of time to death from upper tract urothelial carcinoma. We were unable to conduct any of the preplanned subgroup analyses, particularly those based on operative approach, pathologic stage, and method of bladder cuff excision.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Xin发布了新的文献求助10
1秒前
李健的应助被小萝卜采纳,获得10
1秒前
水知寒完成签到,获得积分0
1秒前
灰鸽子发布了新的文献求助10
1秒前
2秒前
11111265完成签到,获得积分20
2秒前
miaotiao发布了新的文献求助10
3秒前
3秒前
杨小鸿完成签到,获得积分20
4秒前
5秒前
顺利的远航完成签到 ,获得积分10
5秒前
烟花的应助被Xin采纳,获得10
6秒前
挚友发布了新的文献求助10
6秒前
7秒前
7秒前
怪怪发布了新的文献求助10
8秒前
激昂的夏旋完成签到,获得积分20
8秒前
8秒前
记得每天听听力完成签到,获得积分10
8秒前
9秒前
miumiu521发布了新的文献求助10
9秒前
10秒前
Jigsaw发布了新的文献求助10
10秒前
10秒前
11秒前
诚心巧凡发布了新的文献求助10
12秒前
Echo完成签到 ,获得积分10
12秒前
科研通AI6.3的应助被小慈采纳,获得10
14秒前
15秒前
怪怪完成签到,获得积分10
16秒前
ou发布了新的文献求助10
16秒前
顺利的飞荷完成签到,获得积分0
16秒前
18秒前
miaotiao完成签到,获得积分10
18秒前
18秒前
19秒前
MZ发布了新的文献求助10
21秒前
万能图书馆的应助被邬梦寒采纳,获得20
24秒前
24秒前
vivre223完成签到 ,获得积分10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193729
求助须知:如何正确求助?哪些是违规求助? 9579876
关于积分的说明 21868333
捐赠科研通 7793519
什么是DOI,文献DOI怎么找? 3437414
关于科研通互助平台的介绍 2560856
邀请新用户注册赠送积分活动 2484216